Wird geladen...

Immunotherapy of Head and Neck Cancer: Current and Future Considerations

Patients with head and neck squamous cell carcinoma (HNSCC) are at considerable risk for death, with 5-year relative survival rates of approximately 60%. The profound multifaceted deficiencies in cell-mediated immunity that persist in most patients after treatment may be related to the high rates of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rapidis, Alexander D., Wolf, Gregory T.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi Publishing Corporation 2009
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2723756/
https://ncbi.nlm.nih.gov/pubmed/19680453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/346345
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!